{"id":"https://openalex.org/W2406237407","doi":"https://doi.org/10.1021/jm500695e","title":"Recent Advances in the Development of Acetyl-CoA Carboxylase (ACC) Inhibitors for the Treatment of Metabolic Disease","display_name":"Recent Advances in the Development of Acetyl-CoA Carboxylase (ACC) Inhibitors for the Treatment of Metabolic Disease","alternate_titles":[],"publication_year":2014,"publication_date":"2014-11-03","ids":{"openalex":"https://openalex.org/W2406237407","doi":"https://doi.org/10.1021/jm500695e","mag":"2406237407","pmid":"https://pubmed.ncbi.nlm.nih.gov/25333641"},"language":"en","primary_location":{"id":"doi:10.1021/jm500695e","doi":"https://doi.org/10.1021/jm500695e","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm500695e","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2406237407"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025496489","display_name":"Matthew P. Bourbeau","orcid":"https://orcid.org/0009-0007-9061-7459","observed_orcids":["https://orcid.org/0009-0007-9061-7459"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Matthew P. Bourbeau","raw_affiliation_strings":["Department\rof Medicinal Chemistry, and Department of\rMolecular Structure and Characterization, Amgen, Inc., 1 Amgen\rCenter Drive, Thousand Oaks, California 91320, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department\rof Medicinal Chemistry, and Department of\rMolecular Structure and Characterization, Amgen, Inc., 1 Amgen\rCenter Drive, Thousand Oaks, California 91320, United States","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045988901","display_name":"Michael D. Bartberger","orcid":"https://orcid.org/0000-0002-5167-3139","observed_orcids":["https://orcid.org/0000-0002-5167-3139"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael D. Bartberger","raw_affiliation_strings":["Department\rof Medicinal Chemistry, and Department of\rMolecular Structure and Characterization, Amgen, Inc., 1 Amgen\rCenter Drive, Thousand Oaks, California 91320, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department\rof Medicinal Chemistry, and Department of\rMolecular Structure and Characterization, Amgen, Inc., 1 Amgen\rCenter Drive, Thousand Oaks, California 91320, United States","institution_ids":["https://openalex.org/I1320553840"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5025496489"],"corresponding_institution_ids":["https://openalex.org/I1320553840"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":1.6887,"has_fulltext":false,"cited_by_count":67,"citation_normalized_percentile":{"value":0.83967419,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"58","issue":"2","first_page":"525","last_page":"536"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.4357999861240387,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.4357999861240387,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.4018999934196472,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.04230000078678131,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acetyl-coa-carboxylase-inhibitors","display_name":"acetyl-CoA carboxylase inhibitors","score":0.9869999885559082},{"id":"https://openalex.org/keywords/metabolic-disorders","display_name":"metabolic disorders","score":0.8399999737739563},{"id":"https://openalex.org/keywords/in-vivo-efficacy","display_name":"in vivo efficacy","score":0.640999972820282},{"id":"https://openalex.org/keywords/rodent-models","display_name":"rodent models","score":0.9110000133514404},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.7110000252723694},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.6830000281333923},{"id":"https://openalex.org/keywords/fatty-acid-synthesis-inhibition","display_name":"fatty acid synthesis inhibition","score":0.7129999995231628}],"concepts":[{"id":"https://openalex.org/C2779318131","wikidata":"https://www.wikidata.org/wiki/Q21199067","display_name":"Acetyl-CoA carboxylase","level":4,"score":0.6202730536460876},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6113264560699463},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5499937534332275},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5402588248252869},{"id":"https://openalex.org/C2991848491","wikidata":"https://www.wikidata.org/wiki/Q2351083","display_name":"Metabolic disease","level":2,"score":0.49899864196777344},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.43815451860427856},{"id":"https://openalex.org/C2988867146","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Human disease","level":3,"score":0.42865073680877686},{"id":"https://openalex.org/C140137476","wikidata":"https://www.wikidata.org/wiki/Q21114968","display_name":"Pyruvate carboxylase","level":3,"score":0.41531237959861755},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.26832258701324463},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24750420451164246},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23087453842163086},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.21942976117134094},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.12135213613510132},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10317903757095337}],"mesh":[{"descriptor_ui":"D000103","descriptor_name":"Acetyl-CoA Carboxylase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000103","descriptor_name":"Acetyl-CoA Carboxylase","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008659","descriptor_name":"Metabolic Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017434","descriptor_name":"Protein Structure, Tertiary","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm500695e","doi":"https://doi.org/10.1021/jm500695e","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm500695e","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:25333641","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25333641","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":57,"referenced_works":["https://openalex.org/W1523556166","https://openalex.org/W1564338477","https://openalex.org/W1590008587","https://openalex.org/W1620396263","https://openalex.org/W1879141391","https://openalex.org/W1964457740","https://openalex.org/W1964817640","https://openalex.org/W1965513318","https://openalex.org/W1965737130","https://openalex.org/W1965939933","https://openalex.org/W1967273388","https://openalex.org/W1986517810","https://openalex.org/W1992001904","https://openalex.org/W2007486805","https://openalex.org/W2007527212","https://openalex.org/W2014956738","https://openalex.org/W2017926200","https://openalex.org/W2022392364","https://openalex.org/W2025924734","https://openalex.org/W2039890062","https://openalex.org/W2042837500","https://openalex.org/W2048733863","https://openalex.org/W2051790871","https://openalex.org/W2062144221","https://openalex.org/W2062805502","https://openalex.org/W2065034018","https://openalex.org/W2073623117","https://openalex.org/W2074274985","https://openalex.org/W2077098208","https://openalex.org/W2078941483","https://openalex.org/W2084211582","https://openalex.org/W2084320367","https://openalex.org/W2090415246","https://openalex.org/W2093519481","https://openalex.org/W2098014852","https://openalex.org/W2100560975","https://openalex.org/W2109069233","https://openalex.org/W2110549950","https://openalex.org/W2114853986","https://openalex.org/W2114874359","https://openalex.org/W2118256928","https://openalex.org/W2120692492","https://openalex.org/W2122649002","https://openalex.org/W2137832556","https://openalex.org/W2145158439","https://openalex.org/W2152558776","https://openalex.org/W2164921236","https://openalex.org/W2169806986","https://openalex.org/W2178164598","https://openalex.org/W2312974788","https://openalex.org/W2313034080","https://openalex.org/W2313259485","https://openalex.org/W2315397080","https://openalex.org/W2324302076","https://openalex.org/W2341314446","https://openalex.org/W2397695929","https://openalex.org/W2952224933"],"related_works":["https://openalex.org/W1523556166","https://openalex.org/W2969860806","https://openalex.org/W3006071110","https://openalex.org/W1974937838","https://openalex.org/W2055779765","https://openalex.org/W2114874359","https://openalex.org/W1992001904","https://openalex.org/W2170647741","https://openalex.org/W2004930290","https://openalex.org/W2145958122"],"abstract_inverted_index":{"The":[0,78],"development":[1],"of":[2,10,25,53,65,92,98],"acetyl-CoA":[3],"carboxylase":[4],"(ACC)":[5],"inhibitors":[6,31],"for":[7,20,95],"the":[8,17,89,96],"treatment":[9,97],"metabolic":[11,66],"disease":[12],"has":[13,71],"been":[14,33,72],"pursued":[15],"by":[16,35,59],"pharmaceutical":[18],"industry":[19],"some":[21],"time.":[22],"A":[23],"number":[24],"recent":[26,47],"disclosures":[27],"describing":[28],"potent":[29],"ACC":[30,93],"have":[32],"reported":[34],"multiple":[36],"research":[37],"groups.":[38],"Unlike":[39],"many":[40],"prior":[41],"publications":[42,48],"in":[43,54,62],"this":[44],"area,":[45],"more":[46],"contain":[49],"a":[50],"significant":[51],"amount":[52],"vivo":[55],"efficacy":[56],"data":[57],"generated":[58],"long-term":[60],"experiments":[61],"rodent":[63],"models":[64],"disease.":[67,100],"Additionally,":[68],"one":[69],"compound":[70],"advanced":[73],"to":[74,86],"human":[75,99],"clinical":[76],"studies.":[77],"results":[79],"from":[80],"these":[81],"studies":[82],"should":[83],"allow":[84],"researchers":[85],"better":[87],"gauge":[88],"potential":[90],"utility":[91],"inhibition":[94]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2406237407","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
